- Figure 5 . Diagrammatic representation of an ileocolic blind loop developing after side-to-side anastomosis of bypassed ileal segment to ascending colon Figure 6 . Diagrammatic representation of end-to-side resiting of bypassed segment to ensure peristaltic emptying. Bypassed segment is secured to the posterior peritoneum to prevent intussusception whilst it is true that both patients developed diarrhoea, there were reasons other than the blind loop syndrome for this to occur. In the first case the terminal ileum and ileocaecal valve had been removed, and diarrhoea is well recorded following this procedure (Fehr & Deucher 1979) . In the second case, jejunoileal bypass had resulted in a very short small bowel, once again a situation complicated by diarrhoea.
It is interesting that the first case responded to metronidazole and although the blind loop syndrome (characterized by diarrhoea, steatorrhoea, anaemia, loss of weight, abdominal pain and multiple vitamin deficiencies) may have compounded the other reasons for diarrhoea, its existence was never proved. Antibiotics were used apparently with some effect in the second case but the main feature was pain, probably due to distension of the blind loop. 0141-0768/80/120884-03/$02.00/0 Because of the complications described above it would seem desirable to avoid either side-to-side (e.g. ileum to colon) or end-to-side (e.g. oesophagus to jejunum) anastomoses in which a non-emptying blind loop is created. rheumatoid arthritis was made and she was treated with prednisone 5 mg daily (1971) (1972) (1973) (1974) (1975) (1976) (1977) (1978) (1979) and gold 20 mg per week. The arthritis responded but the gold was discontinued after two months because she developed a rash, stomatitis and eosinophilia. In 1972hydroxychloroquine (200 mg daily) was commenced, but was discontinued after a few weeks as it also caused a generalized dermatitis. She was unable to tolerate non-steroid anti-inflammatory drugs and was maintained on prednisome 5 mg. In 1979 her joints deteriorated and she was started on penicillamine 375 mg daily with a good result; however, after four months proteinuria developed and the penicillamine was stopped. Two months later it was reintroduced, slowly increasing from 125mg to 250 mg daily. After one month on 250 mg daily she developed a rash, muscle weakness and proteinuria. There was severe pruritus. The penicillamine was stopped and prednisone increased to 30 mg daily.
References
Examination revealed periorbital oedema and erythema, erythema of the face ( Figure I) , limbs, trunk, knuckles, interphalangeal joints, ragged cuticles and nail fold infarcts, and vasculitic lesions. The proximal and truncal muscles were weak. There was no evidence of active arthritis. Investigations: Full blood count and ESR were normal. Rheumatoid factor was negative. ANF was positive (titre I in 10), but DNA binding and complement levels were normal. Antismooth muscle antibodies were present (titre I in 10). Antistriated muscle antibodies were I band positive (titre I in 10) and A band negative. Muscle enzymes were repeatedly normal, urine creatine excretion was raised at 2.54 mmol/24 hours (normal range < 0.8). Electromyography (EMG) revealed findings typical of a myopathy.
Histopathology of the skin showed a loose upper dermal infiltrate of mononuclear cells and patchy basal cell liquefaction degeneration. Numerous colloid bodies were present in the epidermis (Figure 2 ). This appearance is consistent with dermatomyositis, but more typical of lichenoid drug eruption. Immunofluorescence of involved skin showed IgG deposits and fibrin at the dermo-epidermal junction.
Muscle biopsy of the deltoid muscle, which was clinically weak, showed foci of lymphocytes between the muscle bundles and attenuated abnormal muscle fibres. Immunofluorescence of involved muscle showed IgG at the sarcolemmal basement membrane. X-rays of hands, feet and chest were all normal.
The rash and weakness did not respond to increased doses of steroids (prednisone 30 mg for two months), antihistamines or azathioprine (150 mg daily for three weeks). There has been a slow spontaneous remission independent of treatment. Her strength is now normal, the rash much less florid and the pruritus has abated; she is taking prednisone 10 mg daily.
Discussion
This woman developed dermatomyositis whilst taking penicillamine. Her previous reaction to gold made it likely that she would develop adverse cutaneous reactions to penicillamine (Webley & Coomes 1978) . Patients with underlying immunological disorders (e.g. rheumatoid arthritis) are also more prone to adverse drug reactions. It is very likely that penicillamine was the cause of the dermatomyositis. The simultaneous occurrence of proteinuria and dermatomyositis, the skin histopathology and the slow spontaneous resolution of the dermatomyositis after withdrawal of penicillamine all suggest that this drug was the cause of the dermatomyositis.
Dermatomyositis is one of the rarest of the adverse reactions to penicillamine. It has been reported twice previously (Fernandes et al. 1977 , Simpson & Golding 1979 . Polymyositis has been reported three times (Schraeder et al. 1972 , Bettendorf & Neuhaus 1974 , Nishikai et al. 1974 . Most of these patients had an underlying immunological disease, 3 having rheumatoid arthritis. Our patient has certain features in common with the other 2 cases of penicillamineinduced dermatomyositis: they were female, had arthritis, and positive ANF, but only one of the cases had a previous reaction to gold (Fernandes et al. 1977) . However, skin histology has not been typical of dermatomyositis, and immunoglobulin deposits at the dermo-epidermal junction were also found in the one other case in which a skin biopsy was performed (Simpson & Golding 1979) . All the cases have had biochemical evidence of myositis, namely raised urine creatine excretion with normal or minimally raised serum muscle enzymes. The EMG revealed features of a myopathy in one case (Fernandes et af. 1977) . All 3 patients had a positive ANF.
There have been numerous cutaneous reactions attributed to penicillamine (O'Brien 1980 , Stein et al. 1980 .The acute reactions manifest by urticaria and eosinophilia may be IgE mediated. Long-term treatment causes structural changes in collagen and connective tissue. Dermatomyositis is best considered with those cutaneous adverse reactions that are mediated by autoimmune mechanisms, i.e. pemphigus and lupus erythematosus. Penicillamine therapy is associated with the development of autoantibodies (Zilko et al. 1977) . DNA antibodies are present in patients with penicillamine-induced systemic lupus erythematosus (Kirby et al. 1979) . Epithelial antibodies occur in patients with penicillamine-induced pemphigus (Marsden et al. 1976) .The mechanism by which penicillamine causes dermatomyositis may be similar, i.e. by stimulating an autoimmune process or unmasking a sequestered antigen. The presence of immunoglobulin deposits at the sarcolemmal basement membrane would support an autoimmune aetiology.
Dermatomyositis is a rare complication of penicillamine therapy. It differs from idiopathic dermatomyositis in skin histopathology which may show features of a drug reaction or vasculitis, the EMG which may be normal or suggestive of a myopathy, and the biochemical findings which are characterized by normal or slightly raised serum muscle enzymes.
